Skip to main content

Published locations for Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial

User login

  • Reset your password
  • /content/alzheimers-disease-antibody-crenezumab-doesnt-deliver-phase-ii-trial
  • /familypracticenews/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt-deliver
  • /internalmedicinenews/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt-deliver
  • /psychiatry/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt-deliver-phase-ii
  • /internalmedicine/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt-deliver
  • /neurology/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt-deliver-phase-ii
  • /familymedicine/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt-deliver-phase
  • /clinicalneurologynews/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt-deliver
  • /clinicalpsychiatrynews/article/85822/geriatrics/alzheimers-disease-antibody-crenezumab-doesnt